Zoic Capital

zoiccapital.com

VCMatch tracks Zoic Capital as an investor focused on Biotech, Healthtech, and Medtech companies, Seed and Series A rounds, and United States and Seattle, Wa markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Seed, Series A

Focus Areas

Biotech, Healthtech, Medtech

Geography

United States and Seattle, WA

Investment Thesis

Zoic Capital partners with visionary founders at the intersection of hard science and impactful solutions, focusing on frontier technologies backed by robust intellectual property. Founded in 2014 to address the systematic underfunding of early-stage health technology startups, the firm invests from Seed to Series A, focusing on the first three rounds of capital to propel frontier science into commercial success. The firm’s foundational investment thesis is that “10X returns are reliably generated only by 10X improvements on the status quo.”

Is Zoic Capital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Zoic Capital is most relevant for founders raising Seed and Series A rounds in Biotech, Healthtech, Medtech, and Deep Tech, especially across United States and Seattle, WA.

Focus statement

Investing in trailblazing ventures in hard science and health technologies with strong IP protection that tackle well-defined global challenges and demonstrate market validation.

Value Add

Deep expertise in frontier science and IP strategy - Managing Director Neal Mody created 3,700 patent claims at Ambature (over half of world patents in superconductor field)
Hands-on operational support beyond capital - provides strategic value including IP development workshops and codeveloping deals with potential acquirers
Rigorous due diligence process - Partner Adrian Berliner reviews over 1,000 health startups annually searching for rare companies with transformative potential
Track record of founder experience - Team includes founders of successful deep-tech companies (Ambature, HDT Bio) and operational leaders from healthcare giants
Focus on rare, de-risked opportunities - Emphasis on identifying most de-risked investments that fit the thesis rather than high-volume investing